1. Home
  2. NEWP vs AMRN Comparison

NEWP vs AMRN Comparison

Compare NEWP & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEWP
  • AMRN
  • Stock Information
  • Founded
  • NEWP 1972
  • AMRN 1989
  • Country
  • NEWP Canada
  • AMRN Ireland
  • Employees
  • NEWP N/A
  • AMRN N/A
  • Industry
  • NEWP
  • AMRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEWP
  • AMRN Health Care
  • Exchange
  • NEWP Nasdaq
  • AMRN Nasdaq
  • Market Cap
  • NEWP 259.4M
  • AMRN 216.0M
  • IPO Year
  • NEWP N/A
  • AMRN 1993
  • Fundamental
  • Price
  • NEWP $1.45
  • AMRN $15.16
  • Analyst Decision
  • NEWP
  • AMRN Strong Sell
  • Analyst Count
  • NEWP 0
  • AMRN 1
  • Target Price
  • NEWP N/A
  • AMRN $12.00
  • AVG Volume (30 Days)
  • NEWP 287.8K
  • AMRN 83.2K
  • Earning Date
  • NEWP 09-23-2025
  • AMRN 07-30-2025
  • Dividend Yield
  • NEWP N/A
  • AMRN N/A
  • EPS Growth
  • NEWP N/A
  • AMRN N/A
  • EPS
  • NEWP N/A
  • AMRN N/A
  • Revenue
  • NEWP N/A
  • AMRN $219,361,000.00
  • Revenue This Year
  • NEWP N/A
  • AMRN N/A
  • Revenue Next Year
  • NEWP N/A
  • AMRN N/A
  • P/E Ratio
  • NEWP N/A
  • AMRN N/A
  • Revenue Growth
  • NEWP N/A
  • AMRN N/A
  • 52 Week Low
  • NEWP $0.93
  • AMRN $7.08
  • 52 Week High
  • NEWP $2.05
  • AMRN $17.49
  • Technical
  • Relative Strength Index (RSI)
  • NEWP 39.89
  • AMRN 49.95
  • Support Level
  • NEWP $1.61
  • AMRN $14.45
  • Resistance Level
  • NEWP $1.71
  • AMRN $15.61
  • Average True Range (ATR)
  • NEWP 0.10
  • AMRN 0.64
  • MACD
  • NEWP -0.04
  • AMRN -0.25
  • Stochastic Oscillator
  • NEWP 13.18
  • AMRN 51.39

About NEWP New Pacific Metals Corp.

New Pacific Metals Corp is a Canadian Mining Issuer, in the business of exploring and developing precious metal properties in Bolivia. The company's projects which are also its reportable segments include Silver Sand; Carangas and Silverstrike.

About AMRN Amarin Corporation plc

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Share on Social Networks: